Sanofi Pasteur and Statens Serum Institut , development and marketing of a new vaccine against Tuberculosis

LYON, France, February 14, 2008 - Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced that it has signed a collaborative research and license agreement with the Statens Serum Institut of Denmark (SSI) for the development and marketing of a new vaccine against tuberculosis (TB), a disease that causes the death of two million people, worldwide, each year... [PDF] Sanofi Pasteur' Press Release - [PDF] Communiqué de Presse de Sanofi Pasteur-